Patrick K Reville, MD, MPH¹, Hagop Kantarjian, MD², Gautam Borthakur, MD¹, Naveen Pemmaraju, MD¹, Naval Daver, MD¹, Courtney D. DiNardo, MD, MSCE¹, Koji Sasaki, MD¹, Nicholas Short, MD³, Ghayas C. Issa, MD¹, Maro Ohanian, DO^1*, Elias Jabbour, MD¹, Guillermo Montalban-Bravo, MD¹, Abhishek Maiti, MBBS¹, Nitin Jain, MD⁴, Alessandra Ferrajoli³, Kapil N. Bhalla, MD¹, Koichi Takahashi, MD, PhD³, Caitlin R. Rausch, PharmD^5*, Danielle Hammond, MD¹, Rashmi Malla, RN, BSN^1*, Kelly Quagliato, MBA^1*, Mark Brandt, BS^1*, Uday R Popat, MD⁶, Marina Konopleva, MD, PhD¹, Guillermo Garcia-Manero, MD⁷, Farhad Ravandi, MD¹ and Tapan M. Kadia, MD¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁵Pharmacy, MD Anderson Cancer Center, Houston, TX
⁶Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX

Dominique R Bollino^1*, Yuchen Liu, MD¹, Osman Mohamed Bah, MBChB^2*, Katherine Caprinolo, RN^2*, Jinoos Zarrabi, BS^2*, Sunita Philip, MBBS, MPH^2*, Ezzat Mostafa, MBChB^2*, Rena G. Lapidus, PhD^1*, Zeba Singh, MD^3*, Michael Kallen, MD^3*, Yi Ning, MD, PhD^3*, Rima Koka, MD, PhD^3*, Maria R. Baer, MD², Sandrine Niyongere, MD², Vu H. Duong, MD, MS², Erin T Strovel, PhD^1*, Molly Graveno, PharmD^2* and Ashkan Emadi, MD, PhD¹

¹University of Maryland School of Medicine, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
²University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
³Department of Pathology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD

Guillermo Garcia-Manero, MD¹, Amanda Przespolewski, DO^2*, Yasmin Abaza, MD³, Michael Byrne, DO⁴, Abraham P. Fong, MD⁵, Feng Jin, PhD^5*, Alison J. Forgie, PhD^5*, Athanasios C. Tsiatis, MD⁵, Shanhong Guan^5* and Harry P. Erba, MD, PhD⁶

¹Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Hematology and Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY
³Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
⁴Department of Medicine, Division of Hematology and Oncology, Vanderbilt University, Nashville, TN
⁵ALX Oncology Inc., South San Francisco, CA
⁶Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC

Klaus H. Metzeler, MD¹, Eric S. Winer, MD², Uwe Platzbecker, MD³, Amit Verma, MD⁴, Daniel J. DeAngelo, MD, PhD², Stefano R. Tarantolo, MD⁵, David A. Sallman, MD⁶, James Dugan, MD^7*, Stefanie Gröpper^8*, Katharina S. Goetze⁹, Chia-Cheng Li^10*, Wanying Zhao^10*, Maureen Lane^10*, Reinhard von Roemeling, MD¹⁰, Samantha Carlisle^11*, Anne Weigert^12*, Matthias Böhme^1*, Anne Sophie Kubasch, MD^13* and Guillermo Garcia-Manero, MD¹⁴

¹Department of Hematology, Cell Therapy and Hemostaseology, University Hospital Leipzig, Leipzig, Germany
²Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
³Medical Clinical and Policlinic 1, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany
⁴Department of Hematology and Medical Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
⁵Nebraska Cancer Specialists, Omaha, NE
⁶Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
⁷Novant Health at Forsyth Medical Center, Winston-Salem, NC
⁸Marien Hospital Düsseldorf, Düsseldorf, Germany
⁹Department of Medicine III, Klinikum rechts der Isar, Technical University Munich (TUM), Munich, Germany
¹⁰Curis, Inc., Lexington, MA
¹¹Monoceros Biosystems, San Diego, CA
¹²Department for Hematology, Cell Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany
¹³Department of Hematology, Cellular Therapy and Hemostaseology, Department of Hematology and Cell Therapy, Medical Clinic and Policlinic I, Leip, Leipzig, Germany
¹⁴Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX

Jayastu Senapati, MD, MBBS, DM^1*, Emmanuel Huante Almanza, MD^2*, Tapan M. Kadia, MD³, Guillermo Montalban-Bravo, MD¹, Stefan Faderl^4*, Koji Sasaki, MD¹, Nicholas Short, MD⁵, Naval Daver, MD⁶, Courtney D. DiNardo, MD, MSCE¹, Lucia Masarova, MD¹, Alessandra Ferrajoli⁵, Elias Jabbour, MD¹, Gautam Borthakur, MD¹, Hind Al Azzawi^1*, Marina Konopleva, MD, PhD⁷, Guillermo Garcia-Manero, MD⁸, Michael Andreeff, MD, PhD¹, Hagop Kantarjian, MD⁹, Farhad Ravandi, MD¹ and Yesid Alvarado, MD¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, University of Texas MD Anderson Cancer Center, Hosuton, TX
³Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁴Jazz Pharmaceuticals, Palo Alto, CA
⁵Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁶MD Anderson Cancer Center, Houston, TX
⁷MD Anderson Cancer Center, Houston, TX
⁸Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
⁹Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Roberto Cairoli^1,2*, Arianna Gatti, PhD^3*, Giovanni Grillo, MD^4*, Monica Fumagalli, MD^5*, Mauro Krampera, MD, PhD^6*, Patrizia Zappasodi^7*, Erika Borlenghi, M.D.^8*, Elisabetta Todisco, MD^9*, Marta Ubezio, MD^10*, Massimo Bernardi, MD^11*, Alfredo Molteni, MD^12*, Claudia Basilico, MD^13*, Mauro Turrini, MD^14*, Rosa Greco, MD^15*, Valentina Mancini, MD^1*, Marta Riva, MD^16*, Beatrice De Marco, MD^17*, Marta Rachele Stefanucci, PhD^18*, Bruno Brando, MD^3*, Silvio Marco Veronese, PhD^19* and Alessandro Beghini, PhD^20*

¹Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
²ASST Grande Ospedale Metropolitano Niguarda, Niguarda Cancer Center, Department of Hematology, MILANO, MI, Italy
³ASST Ovest Milanese, Legnano, Italy
⁴Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy, Italy
⁵Division of Hematology, Ospedale San Gerardo, Monza, Italy
⁶Section of Hematology and Bone Marrow Transplant Unit, Department of Medicine, University of Verona, Verona, Italy
⁷Department of Hematology Oncology, Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
⁸Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
⁹European Institute of Oncology, Milan, ITA
¹⁰Cancer Center, IRCCS Humanitas Research Hospital & Humanitas University, Rozzano, Italy
¹¹Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy
¹²Division of Hematology, ASST Cremona, Cremona, Italy
¹³ASST dei Sette Laghi, Presidio di Varese Osp Circolo Fondazione Macchi, Varese, Italy
¹⁴Dep. of Internal Medicine, Valduce Hospital, Como, Italy
¹⁵Department of Hematology, ASST Grande Ospedale Niguarda, Milan, Italy
¹⁶Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, MI, Italy
¹⁷Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
¹⁸Department of Health Sciences, University of Milan, Milan, Italy
¹⁹Department of Laboratory Medicine, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
²⁰Department of Health Sciences, University of Milan, Milano, Italy

Richard F. Little, MD, MPH¹, Megan Othus, PhD^2,3,4, Sarit Assouline⁵, Sherry Ansher, PHD^6*, Ehab L. Atallah, MD⁷, R. Coleman Lindsley⁸, Boris Freidlin, PHD^6*, Steven D. Gore, MD⁹, Lyndsay Harris, MD^10*, Christopher S. Hourigan, MD¹¹, S. Percy Ivy, MD^12*, Shahanawaz Jiwani, MD, PhD, MS^13*, Erin Langan^14*, Selina M. Luger, MD, FRCPC¹⁵, Laura C. Michaelis, MD¹⁶, Olatoyosi Odenike, MD¹⁷, David Patton^10*, Miguel-Angel Perales, MD¹⁸, Jerald P. Radich, MD¹⁹, Bhanu Ramineni, MS, MS^20*, Jesse J. Salk, MD, PhD^21,22,23, Patrick Stiff, MD²⁴, Wendy Stock, MD²⁵, Richard M. Stone, MD²⁶, Geoffrey L. Uy, MD²⁷, P. Mickey Williams, PhD^13*, Brent L. Wood, MD PhD²⁸, Katherine H Worthington, PHD^14*, Laura M Yee, PHD^20*, Amer M. Zeidan, MD²⁹, Jianqiao Zhang, PHD^20*, Mark R. Litzow, MD³⁰ and Harry P. Erba, MD, PhD³¹

¹National Institutes of Health National Cancer Institute, Bethesda, MD
²Department of Biostatistics, University of Washington School of Public Health, Seattle, WA
³SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA
⁴Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA
⁵Department of Medicine and Oncology, Jewish General Hospital, McGill University, Montreal, Montreal, QC, Canada
⁶Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD
⁷Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
⁸Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁹National Institutes of Health, National Cancer Institute, Rockville, MD
¹⁰National Cancer Institute, Bethesda, MD
¹¹Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD
¹²National Cancer Institute Cancer Therapy Evaluation Program, Rockville, MD
¹³Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD
¹⁴EMMES Corporation LLC, Rockville, MD
¹⁵Cellular Therapy and Transplantation, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA
¹⁶Division of Hematology/Oncology, Department of Medicine, The Medical College of Wisconsin Inc., Milwaukee, WI
¹⁷Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
¹⁸Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁹Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
²⁰National Cancer Institute, Rockville, MD
²¹TwinStrand Biosciences, Seattle, WA
²²Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA
²³Department of Medicine/Division of Medical Oncology, University of Washington, Seattle, WA
²⁴Loyola University Medical Center, Cardinal Bernardin Cancer Center, Maywood, IL
²⁵University of Chicago, Chicago, IL
²⁶Center for Leukemia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²⁷Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO
²⁸Children's Hospital Los Angeles, Los Angeles, CA
²⁹Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT
³⁰Division of Hematology, Mayo Clinic, Rochester, MN
³¹Leukemia Program, Duke University Medical Center, Durham, NC

Anna Sergeeva, PhD^1*, Hong He, MD, PhD^1*, Lisa St John, PhD^1*, Celine Kerros, PhD^2*, Ling Yu^1*, Rolando A. Vedia, MS^1*, Valeria Rodriguez Gonzalez^3*, Sijie Lu, PhD^1*, Gheath Alatrash, PhD, DO¹, Kathryn Cox^1*, Karen Clise-Dwyer, PhD^1*, Shao-Ping Yang, MS^4*, Gregory Lizee, Ph.D^5*, Long Vien^6*, Laura Bover, Ph.D.^6*, Qing Ma, PhD^1*, Mithil Chokshi, PhD^7*, Gang Bao, PhD^7*, M. James You, MD, PhD⁸ and Jeffrey J. Molldrem, MD¹

¹Department of Hematopoietic Biology & Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Evolution of Cancer, Leukemia and Immunity Post Stem cEll Transplant (ECLIPSE), Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX
³The University of Puerto Rico, Houston
⁴Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston
⁵Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston
⁶Monoclonal Antibody Core Facility, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Bioengineering, Rice University, Houston, TX
⁸Department of Hematopathology, University of Texas, MD Anderson Cancer Center, Houston, TX

Vicky Y Lin, PhD^*, Anjushree Iyer^*, Keith Akama, PhD^*, Rujin Cheng, PhD^*, Hong Yang^*, Jonathan Aguayo^*, Betty Li^*, Alan K Kutach, PhD^*, Jie Tang, PhD^*, Daniel Kaplan, PhD^* and Julie M Roda, PhD^*

NGM Biopharmaceuticals, South San Francisco, CA

Jan Philipp Bewersdorf, MD¹, Maximilian F. Stahl, MD², Justin Taylor, MD³, Namrata Sonia Chandhok, MD⁴, Justin Watts, MD⁵, Andriy Derkach, PhD^6*, Mateusz Wysocki^7*, Victoria Kostantakis^7*, Sydney X. Lu, MD, PhD⁸, Jessie Bourcier, MD^9*, Simon Hogg, PhD^10*, Tulasigeri M Totiger, PhD^11*, Omar Abdel-Wahab, MD¹² and Eytan Stein, MD¹³

¹Department of Medicine; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Medical Oncology, Dana-Farber Institute, Boston, MA
³University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL
⁴University of Miami, Miami, FL
⁵Sylvester Comprehensive Cancer Center, University of Miami, Coral Gables, FL
⁶Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Memorial Sloan Kettering Cancer Center, New York, NY
⁸Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁹Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, Neew York, NY
¹⁰Memorial Sloan Kettering Cancer Center, New York
¹¹Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami
¹²Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹³Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Kristin L Koenig, MD¹, Colin Brame^2*, Steven Sher^3*, Larry Beaver, BS^1*, Casey B. Cempre, B.S.^1*, Katie Williams, MS^1*, Matthew Purcell^4*, Bonnie Harrington, DVM, PhD^5*, Yi Chen, PhD^6*, Felai Tan, PhD, MD^7*, Stephen P. Anthony, DO⁶, Yu Chen, MD, PhD^6*, Yue Shen, PhD^6*, John C. Byrd, MD⁸ and Rosa Lapalombella, PhD⁹

¹Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
²The Ohio State University, Columbus
³Division of Hematology, Department of Internal Medicine, THE OHIO STATE UNIVERSITY, COLUMBUS, OH
⁴The Ohio State University, Columbus, OH
⁵Charles River Laboratories, Wilmington
⁶Newave Pharmaceutical Inc., Pleasanton, CA
⁷Newave Pharmaceuticals Inc., Pleasanton, CA
⁸University of Cincinnati College of Medicine, Cincinnati, OH
⁹Department of Internal Medicine, Division of Hematology, College of Medicine, The Ohio State University, Columbus, OH

Joshua F. Zeidner, MD¹, Matthew C. Foster, MD², Mary Johnson^3*, Ying Huang, MS, MA^4*, Ronan T. Swords, MD^5*, Eytan Stein, MD⁶, James M. Foran, MD⁷, Maria R. Baer, MD⁸, Wendy Stock, MD⁹, Yazan F. Madanat, MD¹⁰, Tibor Kovacsovics, MD¹¹, Rebecca L. Olin, MD¹², William G. Blum, MD¹³, Gary J. Schiller, MD¹⁴, Tara L. Lin, MD¹⁵, Robert L. Redner, MD¹⁶, Zeina Al-Mansour, MD^17*, Emily K Curran, MD¹⁸, Nyla A. Heerema, PhD¹⁹, Molly Martycz^20*, Leonard Rosenberg, PhD RPh^21*, Sonja Marcus, MPH^22*, Ashley O. Yocum, PhD^23*, Timothy Chen, PhD^24*, Mona Stefanos^20*, Franchesca Druggan, MSc^25*, Amy Burd, PhD²⁶, Ross L. Levine, MD²⁷, Brian J. Druker²⁸, Uma Borate, MD²⁹, John C. Byrd, MD³⁰ and Alice S. Mims, MD⁴

¹UNC - Lineberger Comprehensive Cancer Center, Chapel Hill, NC
²Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
³Leukemia and Lymphoma Society, Rye Brook, NY
⁴Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
⁵Knight Cancer Institute/ Division of Hematology/Medical Oncology, Oregon Health & Science University, Portland, OR
⁶Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Division of Hematology/Oncology and Blood and Marrow Transplanation and Cellular Therapy, Mayo Clinic, Jacksonville, FL
⁸University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
⁹University of Chicago, Chicago, IL
¹⁰Division of Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern, Dallas, TX
¹¹Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
¹²University of California, San Francisco, San Francisco, CA
¹³Department of Hematology and Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
¹⁴David Geffen School of Medicine at UCLA, Los Angeles, CA
¹⁵University of Kansas, Westwood, KS
¹⁶UPMC Hillman Cancer Center, Pittsburgh, PA
¹⁷UF Health Shands Hospital, University of Florida, Gainesville, FL
¹⁸University of Cincinnati, Cincinnati, OH
¹⁹Department of Pathology, The Ohio State University, Columbus, OH
²⁰The Ohio State University Comprehensive Cancer Center, Columbus, OH
²¹Leukemia & Lymphoma Society, Mount Laurel, NJ
²²Leukemia & Lymphoma Society, Rye Brook, NY
²³The Leukemia & Lymphoma Society, Rye Brook, NY
²⁴Department of Internal Medicine, Division of Hematology, College of Medicine, The Ohio State University, Columbus, OH
²⁵The Ohio State University, Columbus, OH
²⁶The Leukemia & Lymphoma Society, White Plains, NY
²⁷Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY
²⁸Knight Cancer Institute, Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR
²⁹Division of Hematology, The Ohio State University, Columbus, OH
³⁰University of Cincinnati College of Medicine, Cincinnati, OH

Ya-Ning Chan, PhD, RN^1*, Daniel R. Richardson, MD, MSc, MA^2,3, Courtney Berry, BS, MA, BSN, RN, OCN^3*, Stephanie Betancur, BSN, RN^1*, Hayden Michael Dumaw, BS^4*, Todd Schwartz, DrPH^1,4*, Mackenzi Pergolotti, PhD, OTR/L^5*, Susan Coppola, MS, OT/L, OTD, FAOTA^6*, Christopher Jensen, MD^2*, Matthew C. Foster, MD^2,3 and Ashley L. Bryant, PhD, RN, OCN, FAAN¹

¹School of Nursing, University of North Carolina at Chapel Hill, Chapel Hill, NC
²Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
³Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
⁴Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC
⁵Select Medical, ReVital Cancer Rehabilitation, Raleigh, NC
⁶Department of Health Science, University of North Carolina at Chapel Hill, Chapel Hill, NC

Brian A. Jonas, MD, PhD¹, Karen Yee, MD², Paul B. Koller, MD³, Joseph Brandwein, MD⁴, Alice S. Mims, MD⁵, Glenn C. Michelson, MD⁶, Linh Nguyen^6*, Mark R Bray^7*, Emily L Roberts-Thomson^6* and Gautam Borthakur, MD⁸

¹Department of Internal Medicine, Division of Malignant Hematology, Transplantation and Cellular Therapy, University of California Davis School of Medicine, Sacramento, CA
²Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
³Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
⁴Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada
⁵Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
⁶Treadwell Therapeutics, Inc., New York, NY
⁷Treadwell Therapeutics Canada, Inc, Toronto, ON, Canada
⁸Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Nicholas Short, MD¹, TaeKon Kim, MD², Rustin Lovewell, Ph.D.^3*, Elizabeth A. Griffiths, MD⁴, Hetty E. Carraway, MD, MBA⁵, Stephanie Zeidan, M.S.^3*, Elizabeth Knowles^3*, Megan Nelson, RN^3*, Jahangheer Shaik, Ph.D.^3*, Chelsea Zhou, Ph.D.^3*, Emilia Alina Barbu, Ph.D.^3*, Zachary Cusumano, Ph.D.^3*, Subhadip Kundu, PhD^3*, Sasan Sharee, Ph.D.^3*, Ron Copeland, Ph.D.^3*, Dallas Flies, Ph.D.^3*, Solomon Langermann, Ph.D.^3*, Han Myint, MD, FRCP, FRCPath⁶, Jessica K. Altman, MD⁷ and Farhad Ravandi, MD⁸

¹Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
²Division of hematology/oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
³NextCure, Beltsville, MD
⁴Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁵Department of Hematology and Medical Oncology, Taussig Cancer institute, Leukemia Program, Cleveland Clinic, Cleveland, OH
⁶NextCure, Livingston, NJ
⁷Northwestern University, Chicago, IL
⁸Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Calvin Lam¹, Ekta Kapoor^1*, Siyuan Tang^1*, David Oupicky^1* and R. Katherine Hyde, PhD²

¹University of Nebraska Medical Center, Omaha, NE
²Department of Biochemistry and Molecular Biology, and Fred and Pamela Buffet Cancer Center, University of Nebraska Medical Center, Omaha, NE

Hao Jiang^1*, Xudong Wei, PhD², Chunkang Chang, PhD^3*, Hongbing Ma, M.D., Ph.D.^4*, Xuejun Zhang^5* and Xiao-Jun Huang⁶

¹Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Beijing, China
²The Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Zhengzhou, China
³Department of Hematology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai 200233, China, Shanghai, China
⁴Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan, China
⁵Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, China
⁶Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematology Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China

Jan Philipp Bewersdorf, MD^1,2, Rory M. Shallis, MD³, Elad Sharon, MD, MPH^4*, Anne Caldwell^5*, Wei Wei, MD^6*, Abdulraheem Yacoub, MD⁷, Yazan F. Madanat, MD⁸, Joshua F. Zeidner, MD⁹, Jessica K. Altman, MD¹⁰, Olatoyosi Odenike, MD¹¹, Swaroopa Yerrabothala, MD¹², Tibor Kovacsovics, MD¹³, Nikolai A. Podoltsev, MD, PhD¹⁴, Stephanie Halene, MD¹⁵, Richard F. Little, MD, MPH¹⁶, Richard Piekarz, MD, PhD, MS, BA^17*, Steven D. Gore, MD¹⁶, TaeKon Kim, MD¹⁸ and Amer M. Zeidan, MD¹⁹

¹Department of Medicine; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Internal Medicine, YALE UNIVERSITY SCHOOL OF MEDICINE, New Haven, CT
³Department of Internal Medicine, School of Medicine and Yale Cancer Center, Yale University, New Haven, CT
⁴Division of Cancer Treatment and Diagnosis, National Cancer Institute, Cancer Therapy Evaluation Program, Bethesda, MD
⁵Yale Cancer Center, Yale University, New Haven, CT
⁶Department of Biostatistics, Yale School of Public Health, New Haven, CT
⁷The University of Kansas Cancer Center, Leawood, KS
⁸Division of Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern, Dallas, TX
⁹UNC - Lineberger Comprehensive Cancer Center, Chapel Hill, NC
¹⁰Department of Medicine, Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University Feinberg School of Medicine, Chicago, IL
¹¹Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
¹²Hematology Oncology, Dartmouth Hitchcock Medical Center, Lebanon, NH
¹³Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University Of Utah, Salt Lake City, UT
¹⁴Department of Internal Medicine, Section of Hematology, Yale University School of Medicine and Yale Cancer Center, Madison, CT
¹⁵Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT
¹⁶Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD
¹⁷Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Bethesda, MD
¹⁸Division of hematology/oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
¹⁹Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT

Michael Lübbert^1,2, Claudia Schmoor^3*, Tobias Berg^4,5,6,7, Michael Kruszewski^1*, Marcus Matthias Schittenhelm, PD MD^8,9*, Katharina Götze^10,11*, Caroline Pabst^12,13*, Andrea Kündgen^14,15*, Tobias Ma^1*, Anna Frey^16*, Kevin Moschallski^1*, Usama-Ur Rehman^1*, Johannes Jung^1*, Justus Duyster^1*, Manfred Jung^17*, Roland Schüle^18,19*, Ralph Wäsch¹ and Olga Grishina^3*

¹Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Freiburg, Germany
²German Cancer Research Center (DKFZ), Partner Site Freiburg, German Cancer Consortium (DKTK), Freiburg, Germany
³Clinical Trials Unit, University Medical Center Freiburg, Freiburg, Germany
⁴Department of Oncology and Escarpment Cancer Research Institute, McMaster University, Hamilton, ON, Canada
⁵German Cancer Research Center (DKFZ) Partner Site Frankfurt, German Cancer Consortium (DKTK), Frankfurt, Germany
⁶Centre for Discovery in Cancer Research, Hamilton, Canada, McMaster University, Hamilton, ON, Canada
⁷Department of Hematology and Oncology, Goethe University Frankfurt, Frankfurt, ON, Germany
⁸Medical Oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland
⁹German Cancer Research Center (DKFZ) Partner Site Tuebingen, German Cancer Consortium (DKTK), Tuebingen, Germany
¹⁰Department of Internal Medicine III, Technical University of Munich, Klinikum rechts der Isar, Munich, Germany
¹¹German Cancer Research Center (DKFZ) Munich, German Cancer Consortium (DKTK), Munich, Germany
¹²Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany
¹³German Cancer Research Center (DKFZ) Heidelberg, German Cancer Consortium (DKTK), Heidelberg, Germany
¹⁴Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany
¹⁵German Cancer Research Center (DKFZ) Partner Site Duesseldorf, German Cancer Consortium (DKTK), Duesseldorf, Germany
¹⁶Department of Pathology, University Medical Center Freiburg, Freiburg, Germany
¹⁷Institute of Pharmaceutical Sciences, University of Freiburg, Freiburg, Germany
¹⁸Department of Urology and Center for Clinical Research, University Medical Center Freiburg, Freiburg, Germany
¹⁹German Cancer Research Center (DKFZ) Partner Site Freiburg, German Cancer Consortium (DKTK), Freiburg, Germany

Sebastian Bunk, PhD^1*, Martin Hofmann, PhD^1*, Gabriele Pszolla, PhD^1*, Meike Hutt, PhD^1*, Frank Schwöbel, PhD^1*, Felix Unverdorben, PhD^1*, Nadine Aschmoneit, PhD^1*, Claudia Wagner, PhD^1*, Maike Jaworski, PhD^1*, Heiko Schuster, PhD^1*, Florian Schwoerer, PhD^1*, Christoph Schraeder, PhD^1*, Oliver Schoor, PhD^1*, Sarah Missel, PhD^1*, Toni Weinschenk, PhD^2*, Dominik Maurer, PhD^1* and Carsten Reinhardt, MD³

¹Immatics Biotechnologies GmbH, Tuebingen, Germany
²Immatics N.V., Tuebingen, Germany
³immatics biotechnologies GmbH, Muenchen, Germany

Shukaib Arslan, MD¹, Shaun Fleming, FRACP FRCPA^2*, Nitin Jain, MD³, Giovanni Martinelli, MD⁴, Anthony S. Stein, MD⁵, James S. Blachly, MD⁶, Ashish Bajel, MBBS, DM⁷, Antonio Curti, MD, PhD⁸, Giovanni Marconi, MD⁹, Giulia Fabbri, MD, PhD^10*, Yotvat Marmor^11*, Shringi Sharma^11*, Nairouz Elgeioushi, MPH^12*, Natalia Couto-Francisco^13*, Jamal Saeh, PhD^10*, Raoul Tibes¹⁴, Fathima Zumla Cader, MD, PhD, MRCP^13* and Marina Konopleva, MD, PhD³

¹Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
²The Alfred, Melbourne, VIC, Australia
³MD Anderson Cancer Center, Houston, TX
⁴IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori", Meldola, Italy
⁵Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA
⁶Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
⁷Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia
⁸IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia Seragnoli, Bologna, Italy
⁹IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori” - IRST, Bologna, Italy
¹⁰Oncology R&D, AstraZeneca, Boston, MA
¹¹Oncology R&D, AstraZeneca, South San Francisco, CA
¹²Oncology R&D, AstraZeneca, Gaithersburg, MD
¹³Oncology R&D, AstraZeneca, Cambridge, United Kingdom
¹⁴Oncology R&D, AstraZeneca, Wedel, Germany